Lexaria Bioscience Corp.
LEXX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348362
No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Lexaria Bioscience Corp. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −1 vs. Q3 2024
- Shares held
- 1.44M
- +419.7K (+41.1%) vs. Q3 2024
- Total value
- $3.03M
- −$89.0K (−2.9%) vs. Q3 2024
- New holders
- 5
- 8 more added
- Sold out
- 6
- 2 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LEXX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $920.0K |
| Q1 2026 | 28 | $1.17M |
| Q4 2025 | 21 | $1.05M |
| Q3 2025 | 25 | $1.63M |
| Q2 2025 | 21 | $2.00M |
| Q1 2025 | 22 | $2.12M |
| Q4 2024 | 25 | $3.03M |
| Q3 2024 | 27 | $3.25M |
| Q2 2024 | 28 | $5.72M |
| Q1 2024 | 25 | $3.23M |
| Q4 2023 | 20 | $1.49M |
| Q3 2023 | 15 | $1.77M |
| Q2 2023 | 14 | $651.4K |
| Q1 2023 | 17 | $1.85M |
| Q4 2022 | 16 | $1.71M |
| Q3 2022 | 16 | $1.68M |
| Q2 2022 | 16 | $1.67M |
| Q1 2022 | 12 | $1.41M |
| Q4 2021 | 13 | $1.85M |
| Q3 2021 | 11 | $2.83M |
| Q2 2021 | 10 | $2.93M |
| Q1 2021 | 9 | $1.78M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Lexaria Bioscience Corp.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 460,000 | $966.0K | 0.02% | +460,000 | New |
| Invenomic Capital Management LP | 410,731 | $862.5K | 0.05% | −65,042−13.7% | Reduced |
| Geode Capital Management, LLC | 166,679 | $350.1K | 0.00% | +16,288+10.8% | Added |
| Vanguard Group Inc | 127,433 | $267.6K | 0.00% | +18,411+16.9% | Added |
| Raymond James Financial Inc | 60,640 | $127.3K | 0.00% | +60,640 | New |
| State Street Corp | 39,301 | $82.5K | 0.00% | 00.0% | Unchanged |
| Wealth Enhancement Advisory Services, LLC | 28,873 | $60.6K | 0.00% | +15,050+108.9% | Added |
| BlackRock, Inc. | 27,445 | $57.6K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 21,023 | $44.1K | 0.00% | +8,000+61.4% | Added |
| Morgan Stanley | 20,229 | $42.5K | 0.00% | −2,753−12.0% | Reduced |
| Northern Trust Corp | 18,389 | $38.6K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 14,000 | $29.4K | 0.00% | 00.0% | Unchanged |
| Byrne Asset Management LLC | 13,000 | $27.3K | 0.02% | +7,400+132.1% | Added |
| Scotia Capital Inc. | 10,000 | $21.0K | 0.00% | +10,000 | New |
| Royal Bank of Canada | 7,283 | $15.0K | 0.00% | 00.0% | Unchanged |
| Oakworth Capital, Inc. | 5,000 | $10.5K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 4,000 | $8.40K | 0.00% | +1,500+60.0% | Added |
| R Squared Ltd | 2,620 | $5.50K | 0.01% | +2,620 | New |
| Advisor Group Holdings, Inc. | 2,290 | $4.81K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,082 | $4.37K | 0.00% | +738+54.9% | Added |
| Farther Finance Advisors, LLC | 166 | $349 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 126 | $265 | 0.00% | +11+9.6% | Added |
| UBS Group AG | 116 | $244 | 0.00% | +116 | New |
| Sound Income Strategies, LLC | 22 | $47 | 0.00% | 00.0% | Unchanged |
| Gables Capital Management Inc. | 13 | $27 | 0.00% | 00.0% | Unchanged |
| GenTrust, LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Welch Group, LLC | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −18,626−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,257−100.0% | Sold out |
| Aspire Private Capital, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |